skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Thoughts on the earnings released this morning?

Sales increased 21% to $35.4 million for the year-ended December 31, 2019; up 34% to $10.8 million for the fourth quarter; Sales in constant currency increased 24% for the year; 36% for the quarter.

Gross profit increased 15% to $19.0 million for the year; up 34% to $6.1 million for the quarter.

Net income of $793 thousand for the year and $931 thousand for the quarter.

Adjusted EBITDA increased 15% year over year to $7.1 million for the year; up 28% to $2.2 million for the quarter.

Organic growth was 12% for the year; 15% in constant currency. Organic growth was 17% for the quarter, 18% in constant currency.

Cash flow from operations was $6.4 million for the year, up 48%, and total cash at December 31, 2019 was $12.8 million.
Read Answer Asked by Kevin on April 23, 2020
Q: Hi 5i team
What are your top picks for Global/US health care sector ETFs that are listed on TSX , for non hedged and for hedged? Are these better to be in non registered account?
Many thanks.
Read Answer Asked by Willie on April 21, 2020
Q: Hello!
1) I would like to get a good, general US healthcare etf .. what might you recommend now? (Long term income investor)

2) also, I would like an etf that has companies like Sanofi and GSK, at decent weights .. what do you think? I see that VYMI has them but at very low percentages.

Appreciate your advice. Thank you!
Read Answer Asked by Patrik on April 21, 2020
Q: Hi Peter and Staff

As luck would have it after being under water for two years on GILD I dumped it at $63.

It’s gone straight since then mostly because of a possible covid vaccine . I note you like it and while I obviously hope they or someone has a vaccine soon , I wonder about your thoughts for it going forward if they do not come up with a vaccine for covid .

Thanks for all you do
Dennis
Read Answer Asked by Dennis on April 20, 2020
Q: Sorry, I did not mean to limit my question to investing opportunities only in Canada.
What opportunities do you see in the US and would you be able to rank both the Cdn and US suggestions regardless of country in order of preference pls.

Thanks,
Terry
Read Answer Asked by Terry on April 20, 2020
Q: Am needing to get more health exposure into my portfolio. So the question is with say 20 000 to invest, do you put it all into ZLV ETF or is there more growth potential by buying two or three quality stocks like JNJ, PFE and GILD.
Read Answer Asked by Dennis on April 20, 2020
Q: Wow your team is good!

I am short in health care in my portfolio. Can you please provide me with your current five favourite health care buys for growth over the next five years. I am comfortable with volatility, Canada or US, and small, medium or large cap.

Thanks in advance

Read Answer Asked by Brian on April 20, 2020
Q: In answer to @Cheryl, Knight released two news yesterday. The Triumvira repayment shows that Goodman's strategy of battling mostly 'singles' (except the GBT 'homerun') is working.

However, a more meaningful news is that Knight finished repurchasing 100% of their shares buyback under their NCIB. I don't recall a company actually buying "all" of the NCIB allocation. We knew they had bought 78% of it as of March 30, 20 in their Q4 2019 quarterly report. We could have expected they would buy the other 18% but still did it quickly with Stock having dropped a lot in the COVID market (even though they said COVID had not affected their business - well not yet at least).

Question: their NCIB only expires on July 8. Does it mean GUD has to wait until July 8 to request another NCIB to the TSX if they want to continue buying back their shares? Medison still owns 7.5% (10.5M shares) of the company, and I would really like to have GUD arrange a 'block' buyback of Medison's Shares via a 'special NCIB' repurchase to finish the Meir Jacobson involvement once and for all without disrupting the share price, or at least causing uncertainty/concern on that.

Is that possible? And if so, does it have to wait until current NCIB expires in July even as they have completed 100% of the current NCIB already? Thank you!
Read Answer Asked by Jennifer on April 17, 2020
Q: May I have your opinion on CloudMD Software (DOC.CN)? Telemedicine may benefit in this environment.
Read Answer Asked by Manoj on April 17, 2020
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!